Dr. Rugo Discusses Immunotherapy in TNBCOncLiveHope Rugo, MD, professor of medicine, director of the Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center, discusses immunotherapy in triple-negative breast cancer… Continue reading
Boston Business Journal |
Astellas sues former research partners, claiming ‘usurpation’ of stem cell tech
Boston Business Journal A Marlborough-based unit of Japanese drugmaker Astellas Pharma has filed a federal lawsuit accusing two scientists of entering into a collaboration to develop therapeutic stem cells, and then falsely claiming the technology as their own to secure a … |
Boston Business Journal |
Astellas sues former research partners, claiming ‘usurpation’ of stem cell tech
Boston Business Journal A Marlborough-based unit of Japanese drugmaker Astellas Pharma has filed a federal lawsuit accusing two scientists of entering into a collaboration to develop therapeutic stem cells, and then falsely claiming the technology as their own to secure a … |
Live Science |
A Breathtaking New GIF Shows CRISPR Chewing Up DNA
Live Science CRISPR is the set of molecular scissors that’s changing the world. It’s an enzyme that cuts DNA, and scientists figured out in 2012 that they could deploy it for cheap, effective gene editing: Just tag the CRISPR molecule with a bit of RNA (a slim … CRISPR Gene-Editing Technology Could Hold Key To Understanding AddictionForbes This Incredible Footage Shows CRISPR Editing DNA in Real TimeScienceAlert CRISPR Can Now Edit Genes Using Nanoparticles Instead of VirusesMotherboard The Atlantic –Xconomy –Genetic Engineering & Biotechnology News –Nature all 50 news articles » |
Spectrum |
Scientists move closer to gene therapy for Rett syndrome
Spectrum In 2007, researchers used genetic tools to reinstate MECP2 levels in juvenile and adult Rett mice, and found that this manipulation reverses many of the animals’ Rett-like features. This finding suggested that gene therapy — using a harmless virus to … |
Spectrum |
Scientists move closer to gene therapy for Rett syndrome
Spectrum In 2007, researchers used genetic tools to reinstate MECP2 levels in juvenile and adult Rett mice, and found that this manipulation reverses many of the animals’ Rett-like features. This finding suggested that gene therapy — using a harmless virus to … |